
|Articles|March 15, 2003
Intravitreal corticosteroid promising for wet AMD
Orlando-Intravitreal triamcinolone acetonide may be a therapeutic option for stabilizing or improving vision in eyes with exudative age-related macular degeneration (AMD), said Jost B. Jonas, MD, at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























